Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinoline compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor

Quinoline compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor

US Patent 10160744 · Granted Dec 25, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fused heterocyclic compounds as S1P modulators2020
Inhibitor compounds of phosphodiesterase type 10A2019
Fused (hetero)cyclic compounds as S1P modulators2019
Substituted pyrazolopyrimidines and method of use2018
Tricyclic quinoline and quinoxaline derivatives2018
Tricyclic quinoline and quinoxaline derivatives2018
Tricyclic quinoline and quinoxaline derivatives2018
Tricyclic quinoline and quinoxaline derivatives2018
Inhibitor compounds of phosphodiesterase type 10A2018
Modulators of 5-HT receptors and methods of use thereof2018
Oxindole derivatives carrying an amine-substituted piperidyl-acetidinyl substitu2018
Inhibitor compounds of phosphodiesterase type 10A2018